The FinnProstate Group (FP), or FinnProstate Study Group, is a group of scientific researchers in Finland who have conducted a series of clinical trials of treatments for prostate cancer. The first publication by the group was in 1985 and the latest publication was in 2019.
The studies conducted by the FinnProstate group include the following:
A related study, by the Finnish Zoladex Multicentre Study Group, assessed polyestradiol phosphate versus goserelin for advanced prostate cancer. A British group also assessed polyestradiol phosphate 160 mg/month versus orchiectomy for advanced prostate cancer. The SPCG-5 trial assessed polyestradiol phosphate 240 mg/month versus combined androgen blockade (triptorelin or orchiectomy plus flutamide) for advanced prostate cancer.